Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
In spite of the relatively cheap prices, insiders made the decision to sell US$7.7m worth of stock in the last 12 months. This could be a warning indicator of vulnerabilities in the future. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing. View our latest analysis for Alnylam Pharmaceuticals The Last 12 Months Of Insider Transactions At Alnylam Pharmaceuticals Notably, that recent sale by Yvonne Greenstreet is the biggest insider sale of Alnylam Pharmaceuticals shares that we've seen in the last year. So it's clear an insider wanted to take some cash off the table, even below the current price of US$243. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. However, while insider selling is sometimes discouraging,
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Three Undervalued Stocks With Intrinsic Discounts Ranging From 33.2% To 39.6% [Yahoo! Finance]Yahoo! Finance
- An Intrinsic Calculation For Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Suggests It's 50% Undervalued [Yahoo! Finance]Yahoo! Finance
- RNA-based Therapeutics and Vaccines Market Value to Surpass $1.24 billion by 2034, With a CAGR of 21.3% [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $248.00. They now have a "neutral" rating on the stock.MarketBeat
- Three Value Stocks With Discounts Ranging From 18.9% To 43.5% Below Intrinsic Estimates [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 5/2/24 - Beat
ALNY
Sec Filings
- 6/27/24 - Form 4
- 6/26/24 - Form 4
- 6/26/24 - Form 4
- ALNY's page on the SEC website